Li G - Search Results

1

Machine learning model for predicting physical activity related bleeding risk in Chinese boys with haemophilia A.

Ai D, Cui C, Tang Y, Wang Y, Zhang N, Zhang C, Zhen Y, Li G, Huang K, Liu G, Chen Z, Zhang W, Wu R. Ai D, et al. Among authors: li g. Thromb Res. 2023 Dec;232:43-53. doi: 10.1016/j.thromres.2023.10.012. Epub 2023 Oct 21. Thromb Res. 2023. PMID: 37931538

2

Arylation of α-pivaloxyl ketones with arylboronic reagents via Ni-catalyzed sp3 C-O activation.

Huang K, Li G, Huang WP, Yu DG, Shi ZJ. Huang K, et al. Among authors: li g. Chem Commun (Camb). 2011 Jul 7;47(25):7224-6. doi: 10.1039/c1cc11193k. Epub 2011 May 27. Chem Commun (Camb). 2011. PMID: 21623433

3

[A cross-sectional survey of coagulation factor VIII inhibitor in children with hemophilia A].

Wei Q, Li G, Tang L, Chen Z, Zhen Y, Wu X, Zhang N, Zhang J, Yu G, Wu R. Wei Q, et al. Among authors: li g. Zhonghua Er Ke Za Zhi. 2014 Feb;52(2):99-102. Zhonghua Er Ke Za Zhi. 2014. PMID: 24739719 Chinese.

4

Pharmacokinetic Studies of Factor VIII in Chinese Boys with Severe Hemophilia A: A Single-Center Study.

Chen ZP, Li PJ, Li G, Tang L, Zhen YZ, Wu XY, Cheng XL, Luke KH, Blanchette VS, Poon MC, Ding QL, Wu RH. Chen ZP, et al. Among authors: li g, li pj. Chin Med J (Engl). 2018 Aug 5;131(15):1780-1785. doi: 10.4103/0366-6999.233604. Chin Med J (Engl). 2018. PMID: 29848837 Free PMC article.

5

Low-dose immune tolerance induction for children with hemophilia A with poor-risk high-titer inhibitors: A pilot study in China.

Li Z, Chen Z, Cheng X, Wu X, Li G, Zhen Y, Cai S, Poon MC, Wu R. Li Z, et al. Among authors: li g. Res Pract Thromb Haemost. 2019 Aug 9;3(4):741-748. doi: 10.1002/rth2.12248. eCollection 2019 Oct. Res Pract Thromb Haemost. 2019. PMID: 31624794 Free PMC article.

6

Bleeds and imaging scoring scales in relation to pharmacokinetics of coagulation factor VIII in Chinese pediatric patients with severe hemophilia A.

Huang K, Chen Z, Li G, Zhen Y, Wu X, Zhang N, Wu R. Huang K, et al. Among authors: li g. Thromb Res. 2020 Sep;193:83-85. doi: 10.1016/j.thromres.2020.05.043. Epub 2020 May 28. Thromb Res. 2020. PMID: 32531547 No abstract available.

7

A previously treated severe haemophilia A patient developed high-titre inhibitor after vaccinations.

Li Z, Chen Z, Cheng X, Wu X, Li G, Zhen Y, Poon MC, Wu R. Li Z, et al. Among authors: li g. Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420934618. doi: 10.1177/2058738420934618. Int J Immunopathol Pharmacol. 2020. PMID: 32627611 Free PMC article.

8

Comparative pharmacokinetics of Kogenate FS and Kovaltry in 14 Chinese paediatric patients with haemophilia A: A single-centre study.

Huang K, Li G, Zhen Y, Wu X, Chen Z, Wu R. Huang K, et al. Among authors: li g. Haemophilia. 2021 Mar;27(2):e287-e290. doi: 10.1111/hae.14163. Epub 2020 Sep 30. Haemophilia. 2021. PMID: 32997865 No abstract available.

9

A low-dose immune tolerance induction (ITI) protocol incorporating immunosuppressive agents in haemophilia A children with high-titre factor VIII inhibitor and poor-ITI prognostic risk.

Li Z, Chen Z, Cheng X, Liu G, Wu X, Li G, Zhen Y, Cai S, Poon MC, Wu R. Li Z, et al. Among authors: li g. Haemophilia. 2021 Jul;27(4):e469-e472. doi: 10.1111/hae.14157. Epub 2020 Nov 20. Haemophilia. 2021. PMID: 33216409 No abstract available.

10

Pharmacokinetic study of Kovaltry in thirty-five pediatric patients aged <12 years with severe hemophilia A.

Huang K, Zhen Y, Li G, Wu X, Wu R, Chen Z. Huang K, et al. Among authors: li g. Haemophilia. 2021 May;27(3):e340-e346. doi: 10.1111/hae.14276. Epub 2021 Mar 1. Haemophilia. 2021. PMID: 33645868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49,426 results

Search Page

Filters